Endometrial cancer (EC) is the fifth most common cancer in women worldwide. Global
estimates show rising incidence rates in both developed and developing countries. Most …

The quest for improved patient outcomes has been a driving force for adoption of novel
surgical innovations across surgical subspecialties. Gynecologic oncology is one such …

OBJECTIVE: Define subgroups of patients at highest risk for major morbidity and mortality
after a traditional approach of maximal surgical efforts followed by chemotherapy for …

Objectives To refine models to predict surgical morbidity and 90-day mortality after primary
debulking surgery (PDS) for advanced epithelial ovarian cancer (EOC). Methods Women …

OBJECTIVE: Cytoreductive surgery is associated with extensive morbidity and may delay
chemotherapy. We examined the associations among cytoreduction, perioperative …

Background Accompanying co-morbidities in patients with ovarian cancer are of major
relevance for scheduling debulking surgery, especially in the anesthesiological …

Importance Earlier studies on the cost of muscle-invasive bladder cancer treatments lack
granularity and are limited to 180 days. Objective To compare the 1-year costs associated …

Abstract Study Objective Work-related musculoskeletal symptoms (WMSs) are reported to be
increasing in surgeons performing minimally invasive procedures. Therefore, we …

The aim of this article was to compare gene expression programming (GEP) method with
three types of neural networks in the prediction of adverse events of radical hysterectomy in …

Objectives The aim of this study is to determine the impact of obesity on surgical and
oncologic outcomes after primary debulking surgery (PDS) in advanced epithelial ovarian …